Evaluation of N1539 Following Major Surgery
Public ClinicalTrials.gov record NCT02720692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety and tolerability of N1539 in a variety of post-surgical conditions.
Study identification
- NCT ID
- NCT02720692
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 722 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2016 (Actual)
- Primary completion
- Mar 2017 (Actual)
- Completion
- May 2017 (Actual)
- Last update posted
- Jun 22, 2023
2016 – 2017
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Florence | Alabama | 35630 | — |
| Not listed | Montgomery | Alabama | 36116 | — |
| Not listed | Sheffield | Alabama | 35660 | — |
| Not listed | Gilbert | Arizona | 85295 | — |
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Bakersfield | California | 93301 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Tamarac | Florida | 33321 | — |
| Not listed | Tampa | Florida | 33605 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Great Falls | Montana | 59405 | — |
| Not listed | Cleveland | Ohio | 44111 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Tyrone | Pennsylvania | 16686 | — |
| Not listed | Hendersonville | Tennessee | 37075 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02720692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02720692 live on ClinicalTrials.gov.